- Home
- BLRX vs CMBM Comparison
BLRX vs CMBM Comparison
Compare BLRX & CMBM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- CMBM
- Stock Information
- Founded
- BLRX 2003
- CMBM 2011
- Country
- BLRX Israel
- CMBM United States
- Employees
- BLRX N/A
- CMBM N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- CMBM Radio And Television Broadcasting And Communications Equipment
- Sector
- BLRX Health Care
- CMBM Technology
- Exchange
- BLRX Nasdaq
- CMBM Nasdaq
- Market Cap
- BLRX 12.1M
- CMBM 12.7M
- IPO Year
- BLRX 2011
- CMBM 2019
- Fundamental
- Price
- BLRX $5.25
- CMBM $0.32
- Analyst Decision
- BLRX Strong Buy
- CMBM Strong Buy
- Analyst Count
- BLRX 2
- CMBM 2
- Target Price
- BLRX $19.00
- CMBM $5.50
- AVG Volume (30 Days)
- BLRX 1.9M
- CMBM 199.6K
- Earning Date
- BLRX 05-27-2025
- CMBM 06-10-2025
- Dividend Yield
- BLRX N/A
- CMBM N/A
- EPS Growth
- BLRX N/A
- CMBM N/A
- EPS
- BLRX N/A
- CMBM N/A
- Revenue
- BLRX $22,340,000.00
- CMBM $172,215,000.00
- Revenue This Year
- BLRX N/A
- CMBM N/A
- Revenue Next Year
- BLRX N/A
- CMBM $17.87
- P/E Ratio
- BLRX N/A
- CMBM N/A
- Revenue Growth
- BLRX 91.68
- CMBM N/A
- 52 Week Low
- BLRX $2.30
- CMBM $0.23
- 52 Week High
- BLRX $35.60
- CMBM $3.30
- Technical
- Relative Strength Index (RSI)
- BLRX 84.90
- CMBM 30.05
- Support Level
- BLRX $3.32
- CMBM $0.30
- Resistance Level
- BLRX $3.97
- CMBM $0.49
- Average True Range (ATR)
- BLRX 0.46
- CMBM 0.05
- MACD
- BLRX 0.14
- CMBM -0.01
- Stochastic Oscillator
- BLRX 47.06
- CMBM 8.81
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.